Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Liao, Tsai Ling ^a,b   Chen, Yi Ming ^a,b,c   Hsieh, Chia Wei ^a,b   Chen, Hsin Hua ^a,b,c   Lee, Hsiu Chin ^a,b   Hung, Wei Ting ^a,c   Tang, Kuo Tung ^a,b   Chen, Der Yuan ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CIRCULATING MICRORNA; CYTOKINE; LIGAND; MICRORNA; MIRN134 MICRORNA, HUMAN; TOLL LIKE RECEPTOR 3;

ADULT; ADULT ONSET STILL DISEASE; BLOOD; CASE CONTROL STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; METABOLISM; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; UPREGULATION;

ADULT; BASE SEQUENCE; BIOMARKERS; CASE-CONTROL STUDIES; CIRCULATING MICRORNA; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; LIGANDS; MALE; MICRORNAS; STILL'S DISEASE, ADULT-ONSET; TOLL-LIKE RECEPTOR 3; UP-REGULATION;

EID: 85021301590     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-04086-w     Document Type: Article

References (52)

1. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116, 281-297 (2004).
2. Krol, J., Loedige, I. & Filipowicz, W. The widespread regulation of microRNA biogenesis, function, and decay. Nat Rev Genet. 11, 597-610 (2010).
3. Wei, B. & Pei, G. MicroRNAs: critical regulators in Th17 cells and players in diseases. Cell Mol Immunol. 7, 175-181 (2010).
4. Kozomara, A. & Griffiths-Jones, S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 42, D68-73 (2013).
5. Sonkoly, E. & Pivarcsi, A. Advances in microRNAs: implications for immunity and inflammatory disease. J Cell Mol. 13, 24-38 (2009).
6. Pauley, K. M., Cha, S. & Chan, E. K. L. MicroRNA in autoimmunity and autoimmune disease. J Autoimmun. 32, 189-194 (2009).
7. Mu, N. et al. A novel NF-kappaB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis. Sci. Rep. 6, 20059 (2016).
8. Ceribelli, A. et al. MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther. 13, N1-10 (2011).
9. Carlsen, A. L. et al. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 65, 1324-1334 (2013).
10. Zhou, X. et al. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. Sci. Rep. 5, 11251 (2015).
11. Wang, H., Peng, W., Ouyang, X., Li, W. & Dai, Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res. 160, 198-206 (2012).
12. Kadavath, S. & Efthimiou, P. Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med. 22, 1-9 (2015).
13. Rosário, C., Zandman-Goddard, G., Meyron-Holtz, E. G., D'Cruz, D. P. & Shoenfeld, Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catatrophic antiphospholipid syndrome. BMC Med. 11, 185 (2013).
14. Guilpain, P. & Le Quellec, A. About the complexity of adult onset Still's disease⋯ and advances still required for its management. BMC Med. 15, 5 (2017).
15. Maria, A. T. J. et al. Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions. Autoimmun Rev. 13, 1149-1159 (2014).
16. Kawashima, M. et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum. 44, 550-560 (2001).
17. Chen, D. Y., Lan, J. L., Lin, F. J. & Hsieh, T. Y. Proinflammatory Cytokine Profiles in the Sera and in the Pathological Tissues of Patients with Active Untreated Adult Onset Still's Disease. J Rheumatol. 31, 2189-2198 (2004).
18. Choi, J. H. et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol. 30, 2422-2427 (2003).
19. Chen, D. Y., Lan, J. L., Lin, F. J., Hsieh, T. Y. & Wen, M. C. A predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult-onset Still's disease. Ann Rheum Dis. 63, 1300-1306 (2004).
20. Chen, D. Y. et al. Potential Role of Th17 cells in the Pathogenesis of Adult-Onset Still's Disease. Rheumatology (Oxford). 49, 2305-2312 (2010).
21. Priori, R. et al. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis. J Rheumatol. 41, 1118-23 (2014).
22. Chen, D. Y., Hsieh, T. Y., Hsieh, C. W., Lin, F. J. & Lan, J. L. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease. Arthritis Rheum. 57, 1530-1538 (2007).
23. Curtale, G. et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood. 115, 265-273 (2010).
24. Xu, G. et al. MicroRNA-149 negatively regulates TLR-triggered inflammatory response in macrophages by targeting MyD88. J Cell Biochem. 115, 919-927 (2014).
25. Wakabayashi, K. et al. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease. Clin Rheumatol. 32, 999-1005 (2013).
26. Kalali, B. N. et al. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J Immunol. 181, 2694-2704 (2008).
27. Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149-153 (2008).
28. Okamura, H. et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378, 88-91 (1995).
29. Ushio, S. et al. Cloning of the cDNA for human IFN-γ factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol. 156, 4274-4279 (1996).
30. O'Neill, L. A. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol. 18, 3-9 (2006).
31. Joosten, L. A. B., Abdollahi-Roodsaz, S., Dinarello, C. A., O'Neill, L. & Netea, M. G. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 12, 344-357 (2016).
32. Chen, D. Y. et al. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease. Arthritis Res Ther. 15, R39 (2013).
33. O'Neill, L. A., Sheedy, F. J. & McCoy, C. E. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 11, 163-175 (2011).
34. Miyata, R. et al. Poly(I:C) induced microRNA-146a regulates epithelial barrier and secretion of proinflammatory cytokines in human nasal epithelial cells. Eur J Pharmacol. 761, 375-382 (2015).
35. Yin, Q. et al. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol. 82, 5295-5306 (2008).
36. Wouters, J. M., van der Veen, J., van de Putte, L. B. & de Rooij, D. J. Adult onset Still's disease and viral infections. Ann Rheum Dis. 47, 764-767 (1988).
37. Chen, D. Y. et al. Significant association of past parvovirus B19 infection with cytopenia in both adult onset Still's disease and systemic lupus erythematosus patients. Clin Chim Acta. 413, 855-860 (2012).
38. Arlet, J. B., Le, T., Huong, D. B., Pouchot, J. & Piette, J. C. Current concepts on the physiopathology of adult-onset Still's disease. Rev Med Interne. 26, 549-556 (2005).
39. Kim, H. A., An, J. M., Nam, J. Y., Jeon, J. Y. & Suh, C. H. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease. J Rheumatol. 39, 1399-1406 (2012).
40. Aizawa, Y. et al. Cloning and expression of interleukin-18 binding protein. FEBS Lett. 445, 338-342 (1999).
41. Novick, D. et al. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity. 10, 127-136 (1999).
42. Girard, C. et al. Elevated serum levels of free interleukin-18 in adult-onset Still's disease. Rheumatology (Oxford). 55, 2237-2247 (2016).
43. Park, J. H. et al. Natural Killer cell cytolytic function in Korean patients with adult-onset Still's disease. J Rheumatol. 39, 2000-2007 (2012).
44. Weber, A., Wasiliew, P. & Kracht, M. Interleukin-1 (IL-1) pathway. Sci Signal. 3, cm1 (2010).
45. Dinarello, C. A., Novick, D., Kim, S. & Kaplanski, G. Interleukin-18 and IL-18 binding protein. Front Immunol. 4, 1-10 (2013).
46. Magadur-Joly, G. et al. Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis. 54, 587-590 (1995).
47. Ichida, H. et al. Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18. Arthritis Care Res. 66, 642-646 (2014).
48. Yamaguchi, M. et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 19, 424-430 (1992).
49. Rau, M. et al. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. J Rheumatol. 37, 2369-2376 (2010).
50. Hochberg, M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725 (1997).
51. Taganov, K. D., Boldin, M. P., Chang, K. J. & Baltimore, D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA. 103, 12481-12486 (2006).
52. Raymond, C. K., Roberts, B. S., Garrett-Engele, P., Lim, L. P. & Johnson, J. M. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. RNA. 11, 1737-1744 (2005).